Related Experiment Video
Updated: Jul 28, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras
1Department of Developmental, Molecular and Chemical Biology, Sackler School of Graduate Biomedical Sciences, Tufts Medical School, Boston, MA, USA.
Abstract:
RalGDS is a guanine nucleotide exchange factor that promotes the active GTP-bound form of Ral GTPases, RalA and RalB. GTP-bound Ras has the capacity to activate Ral GTPases at least in part by binding to the C-terminal Ras-binding domain (RBD) of RalGDS and directing the protein to Ral GTPases in the plasma membrane. In many cases, activation of Ral proteins complements other Ras effector pathways to carry out a cell function, but in others it opposes them. Moreover, in many cases activation of Ral proteins contributes to the oncogenic potential of Ras. However, in some cell types Ral proteins suppresses tumor formation, suggesting oncogenic stimuli that function through Ras may need to suppress Ral activation in order to transform cells. In this paper, we demonstrate a potential biochemical mechanism for such phenomena by showing that c-Met receptors promote the tyrosine phosphorylation of RalGDS at Y752 in its RBD, which blocks the binding of Ras to RalGDS.
Insights
c-Met receptors phosphorylate Ral Guanine Nucleotide Exchange Simulator (RalGDS) at Y752, blocking Ras binding. This mechanism may suppress Ral protein activation, potentially inhibiting Ras-driven tumor formation in certain cell types.
Area of Science:
- Cellular signaling pathways
- Oncogenesis and tumor suppression
- Protein-protein interactions
Background:
- Ral Guanine Nucleotide Exchange Simulator (RalGDS) activates Ral GTPases (RalA, RalB), crucial for Ras effector pathways.
- Ras-GTP binding to RalGDS's Ras-binding domain (RBD) facilitates Ral GTPase activation.
- Ral protein activation can either complement or oppose Ras-driven cellular functions, including oncogenesis.
Purpose of the Study:
- To elucidate a biochemical mechanism by which c-Met receptors modulate Ras-RalGDS signaling.
- To investigate the role of RalGDS phosphorylation in regulating Ras binding.
- To understand how this regulation might influence Ras-mediated oncogenic potential and tumor suppression.
Main Methods:
- Investigated the interaction between c-Met receptors and RalGDS.
- Utilized tyrosine phosphorylation assays to identify specific phosphorylation sites on RalGDS.
- Performed Ras-binding assays to assess the impact of RalGDS phosphorylation on Ras interaction.
Main Results:
- Demonstrated that c-Met receptors promote tyrosine phosphorylation of RalGDS at Y752 within its Ras-binding domain (RBD).
- Showed that Y752 phosphorylation of RalGDS inhibits the binding of Ras to RalGDS.
- This inhibition of Ras-RalGDS interaction suggests a mechanism for suppressing Ral GTPase activation.
Conclusions:
- c-Met receptor-mediated tyrosine phosphorylation of RalGDS at Y752 represents a novel regulatory mechanism.
- This phosphorylation event serves to block Ras binding to RalGDS, thereby inhibiting Ral GTPase activation.
- This pathway may be critical in contexts where Ras signaling contributes to tumor suppression rather than oncogenesis.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Activation and Inactivation of G Proteins

